Characterization of extended-spectrum β-lactamases and integrons in Escherichia coli isolates in a Spanish hospital

References

1. Bertrand S., Weill F. X., Cloeckaert A., Vrints M., Mairiaux E., Praud K., Dierick K., Wildemauve C., Godard C. other authors 2006; Clonal emergence of extended-spectrum β -lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J Clin Microbiol 44:2897–2903 [CrossRef]
   [Google Scholar]
2. Bischoff K. M., White D. G., Hume M. E., Poole T. L., Nisbet D. J. 2005; The chloramphenicol resistance gene cmlA is disseminated on transferable plasmids that confer multiple-drug resistance in swine Escherichia coli . FEMS Microbiol Lett 243:285–291 [CrossRef]
   [Google Scholar]
3. Brasme L., Nordmann P., Fidel F., Lartigue M. F., Bajolet O., Poirel L., Forte D., Vernet-Garnier V., Madoux J. other authors 2007; Incidence of class A extended-spectrum β -lactamases in Champagne-Ardenne (France): a 1 year prospective study. J Antimicrob Chemother 60:956–964 [CrossRef]
   [Google Scholar]
4. Briñas L., Lantero M., Diego I., Álvarez M., Zarazaga M., Torres C. 2005; Mechanisms of resistance to broad-spectrum-cephalosporins in Escherichia coli isolates recovered in a Spanish hospital. J Antimicrob Chemother 56:1107–1110 [CrossRef]
   [Google Scholar]
5. Cantón R., Novais A., Valverde A., Machado E., Peixe L., Baquero F., Coque T. M. 2008; Prevalence and spread of extended-spectrum β -lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 14:144–153 [CrossRef]
   [Google Scholar]
6. Caroff N., Esparze E., Gautreau D., Richet H., Reynaud A. 2000; Analysis of the effect of −42 and −32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. J Antimicrob Chemother 45:783–788 [CrossRef]
   [Google Scholar]
7. Cartelle M., Tomas M. M., Molina F., Moure R., Villanueva R., Bou G. 2004; High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrob Agents Chemother 48:2308–2313 [CrossRef]
   [Google Scholar]
8. Chang C. Y., Chang L. L., Chang Y. H., Lee T. M., Chang S. F. 2000; Characterisation of drug resistance gene cassettes associated with class 1 integrons in clinical isolates of Escherichia coli from Taiwan, ROC. J Med Microbiol 49:1097–1102
   [Google Scholar]
9. CLSI 2007 Performance Standards for Antimicrobial Susceptibility Testing ; 17th informational supplement, M100–S17 Wayne. PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
10. Du X., Shen Z., Wu B., Xia S., Shen J. 2005; Characterization of class 1 integrons-mediated antibiotic resistance among calf pathogenic Escherichia coli . FEMS Microbiol Lett 245:295–298 [CrossRef]
    [Google Scholar]
11. Eckert C., Gautier V., Saladin-Allard M., Hidri N., Verdet C., Ould-Hocine Z., Barnaud G., Delisle F., Rossier A. other authors 2004; Dissemination of CTX-M-type β -lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 48:1249–1255 [CrossRef]
    [Google Scholar]
12. Eckert C., Gautier V., Arlet G. 2006; DNA sequence analysis of the genetic environment of various bla _CTX-M genes. J Antimicrob Chemother 57:14–23
    [Google Scholar]
13. Hernández J. R., Martínez-Martínez L., Cantón R., Coque T. M., Pascual A. the Spanish Group for Nosocomial Infections (GEIH) 2005; Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β -lactamases in Spain. Antimicrob Agents Chemother 49:2122–2125 [CrossRef]
    [Google Scholar]
14. Ho P. L., Poon W. W. N., Loke S. L., Leung M. S. T., Chow K. H., Wong R. C. W., Yip K. S., Lai E. L., Tsang K. W. T. on behalf of theCOMBAT Study Group. 2007; Community emergence of CTX-M type extended-spectrum β -lactamases among urinary Escherichia coli from women. J Antimicrob Chemother 60:140–144 [CrossRef]
    [Google Scholar]
15. Huletsky A., Knox J. R., Levesque R. C. 1993; Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type β -lactamases probed by site-directed mutagenesis and three-dimensional modeling. J Biol Chem 268:3690–3697
    [Google Scholar]
16. Jarlier V., Nicola M. H., Fournier G., Philippon A. 1988; Extended broad-spectrum β -lactamases conferring transferable resistance to newer β -lactam agents in Enterobacteriaceae : hospital prevalence and susceptibility patterns. Rev Infect Dis 10:867–878 [CrossRef]
    [Google Scholar]
17. Jouini A., Vinué L., Slama K. B., Sáenz Y., Klibi N., Hammami S., Boudabous A., Torres C. 2007; Characterization of CTX-M and SHV extended-spectrum β -lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J Antimicrob Chemother 60:1137–1141 [CrossRef]
    [Google Scholar]
18. Lartigue M. F., Poirel L., Nordmann P. 2004; Diversity of genetic environment of bla _CTX-M genes. FEMS Microbiol Lett 234:201–207 [CrossRef]
    [Google Scholar]
19. Morosini M. I., García-Castillo M., Coque T. M., Valverde A., Novais A., Loza E., Baquero F., Cantón R. 2006; Antibiotic coresistance in extended-spectrum- β -lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline. Antimicrob Agents Chemother 50:2695–2699 [CrossRef]
    [Google Scholar]
20. Mulvey M. R., Bryce E., Boyd D. A., Ofner-Agostini M., Land A. M., Simor A. E., Paton S. 2005; Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian Hospitals. Antimicrob Agents Chemother 49:358–365 [CrossRef]
    [Google Scholar]
21. Nicolas-Chanoine M. H., Blanco J., Leflon-Guibout V., Demarty R., Alonso M. P., Caniça M. M., Park Y. J., Lavigne J. P., Pitout J., Johnson J. R. 2008; Intercontinental emergence of Escherichia coli clone O25 : H4–ST131 producing CTX-M-15. J Antimicrob Chemother 61:273–281
    [Google Scholar]
22. Novais A., Cantón R., Valverde A., Machado E., Galán J. C., Peixe L., Carattoli A., Baquero F., Coque T. M. 2006; Dissemination and persistence of bla _CTX-M-9 are linked to class 1 integrons containing CR1 associated with defective transposon derivatives from Tn 402 located in early antibiotic resistance plasmids of IncH12, IncP1- α , and IncFI groups. Antimicrob Agents Chemother 50:2741–2750 [CrossRef]
    [Google Scholar]
23. Oliver A., Coque T. M., Alonso D., Valverde A., Baquero F., Cantón R. 2005; CTX-M-10 linked to a phage-related element is widely disseminated among Enterobacteriaceae in a Spanish hospital. Antimicrob Agents Chemother 49:1567–1571 [CrossRef]
    [Google Scholar]
24. Paterson D. L., Hujer K. M., Hujer A. M., Yeiser B., Bonomo M. D., Rice L. B., Bonomo R. A. the International Klebsiella Study Group 2003; Extended-spectrum β -lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type β -lactamases. Antimicrob Agents Chemother 47:3554–3560 [CrossRef]
    [Google Scholar]
25. Poirel L., Naas T., Nordmann P. 2008; Genetic support of extended-spectrum β -lactamases. Clin Microbiol Infect 14:75–81 [CrossRef]
    [Google Scholar]
26. Riaño I., Moreno M. A., Teshager T., Sáenz Y., Domínguez L., Torres C. 2006; Detection and characterization of extended-spectrum β -lactamases in Salmonella enterica strains of healthy food animals in Spain. J Antimicrob Chemother 58:844–847 [CrossRef]
    [Google Scholar]
27. Rossolini G. M., D'Andrea M. M., Mugnaioli C. 2008; The spread of CTX-M-type extended-spectrum β -lactamases. Clin Microbiol Infect 14:33–41 [CrossRef]
    [Google Scholar]
28. Sabaté M., Navarro F., Miró E., Campoy S., Mirelis B., Barbé L., Prats G. 2002; Novel complex sul1 -type integron in Escherichia coli carrying bla _CTX-M-9 . Antimicrob Agents Chemother 46:2656–2661 [CrossRef]
    [Google Scholar]
29. Sáenz Y., Briñas L., Domínguez E., Ruiz J., Zarazaga M., Vila J., Torres C. 2004; Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins. Antimicrob Agents Chemother 48:3996–4001 [CrossRef]
    [Google Scholar]
30. Saladin M., Cao V. T. B., Lambert T., Donay J. L., Herrmann J. L., Ould-Hocine Z., Verdet C., Delisle F., Philippon A., Arlet G. 2002; Diversity of CTX-M β -lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 209:161–168
    [Google Scholar]
31. Stapleton P. D., Shannon K. P., French G. L. 1999; Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 β -lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother 43:1206–1210
    [Google Scholar]
32. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B. 1995; Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239
    [Google Scholar]
33. Valverde A., Coque T. M., Sánchez-Moreno M. P., Rollán A., Baquero F., Cantón R. 2004; Dramatic increase in prevalence of fecal carriage of extended-spectrum β -lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 42:4769–4775 [CrossRef]
    [Google Scholar]
34. Velasco C., Romero L., Martínez J. M., Rodríguez-Baño J., Pascual A. 2007; Analysis of plasmids encoding extended-spectrum β -lactamases (ESBLs) from Escherichia coli isolated from non-hospitalised patients in Seville. Int J Antimicrob Agents 29:89–92 [CrossRef]
    [Google Scholar]